Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Treasury Shares (2021 - 2023)

Historic Treasury Shares for Pasithea Therapeutics (KTTA) over the last 3 years, with Q4 2023 value amounting to $266171.0.

  • Pasithea Therapeutics' Treasury Shares fell 9014.18% to $266171.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $266171.0, marking a year-over-year decrease of 9014.18%. This contributed to the annual value of $266171.0 for FY2023, which is 9014.18% down from last year.
  • Latest data reveals that Pasithea Therapeutics reported Treasury Shares of $266171.0 as of Q4 2023, which was down 9014.18% from $266171.0 recorded in Q3 2023.
  • In the past 5 years, Pasithea Therapeutics' Treasury Shares registered a high of $2.7 million during Q4 2022, and its lowest value of $10000.0 during Q4 2021.
  • Over the past 3 years, Pasithea Therapeutics' median Treasury Shares value was $266171.0 (recorded in 2023), while the average stood at $810585.5.
  • In the last 5 years, Pasithea Therapeutics' Treasury Shares skyrocketed by 2690000.0% in 2022 and then crashed by 9014.18% in 2023.
  • Pasithea Therapeutics' Treasury Shares (Quarter) stood at $10000.0 in 2021, then skyrocketed by 26900.0% to $2.7 million in 2022, then crashed by 90.14% to $266171.0 in 2023.
  • Its Treasury Shares was $266171.0 in Q4 2023, compared to $266171.0 in Q3 2023 and $2.7 million in Q4 2022.